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Toward a rapid and accurate point-of-care test
for active pulmonary tuberculosis: Multiplexed
proteomic assay (SOMAscanTM) of human
serum for microbial and host markers
M.A. De Groote, L. Green, D. Sterling, R. Ostroff, N.
Janjic, U. Ochsner
Somalogic, Boulder, USA
Background: A rapid, accurate, and inexpensive tuberculosis
(TB)diagnostic testwouldallowearlier treatmentandreduce trans-
mission.
Methods&Materials:Weused slowoff-ratemodiﬁedaptamers
(SOMAmers) in a highly multiplexed proteomic assay (SOMAscan)
to measure 1129 human proteins and 16 Mtb proteins in serum
samples provided by the Foundation for Innovative New Diagnos-
tics (FIND).
Results: Among the top host serum biomarkers distinguishing
TB from non-TB regardless of the HIV status were kallistatin, TSP4,
gelsolin, and CDON, which were lower in TB compared to non-
TB, and LBP, ITI heavy chain H4, NPS-PLA2, and IP-10, which were
higher in TB.
A 9-marker model performed well in a training set of 173
TB vs. 160 non-TB samples (sens 89% / spec 88%, AUC=0.94), which
was conﬁrmed in a blinded veriﬁcation set of 132 TB vs. 118
non-TB (sens 80% / spec 84%, AUC=0.88). Mtb pathogen-speciﬁc
SOMAmers showed non-speciﬁc background in serum and are
pending analytical optimization to improve performance. Addi-
tional work to improve sensitivity of the host markers is ongoing.
Conclusion: The discovery of robust, quantitative, non-culture
based diagnostic biomarkers of active pulmonary TB has great
potential to facilitate the rapid and accurate diagnosis of TB dis-
ease. Our goal is that a combined host and microbial point-of-care
diagnostic test could ultimately be tested and applied in peripheral
microscopy centers or in primary care clinics.
http://dx.doi.org/10.1016/j.ijid.2014.03.1172
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Identiﬁcation and evaluation of Schistosoma
mansoni proteins as diagnostic targets for
schistosomiasis
P. Ogongo
Institute of Primate Research, Nairobi, Kenya
Background: Demonstration of schistosome eggs in stool/urine
is the deﬁnitive clinical test for clinical examination of schisto-
somiasis but this test has low sensitivity. Antibody based assays
cannot distinguish between past and active infections thus unsuit-
able for follow up after drug administration while molecular
techniques are expensive and unavailable at the point of care cen-
ters. Bioinformatics and Proteomics can be used to characterize
schistosome proteins from different life cycle stages that include
worm gut, worm tegument, egg secretions or released products
of dead eggs that are released into the bloodstream and/or urine
forming good diagnostic targets.
Methods&Materials:Wehave identiﬁed ﬁve schistosome pro-
teins; Cathepsin B (Sm31), Asaparaginyl endopeptidase (Sm32),
schistosome alpha-2 macroglobulin, Sm LMWP and Sm200 tegu-
ment protein using these approaches. Peptide sequences from
these proteins synthesized as multiple antigenic peptides (MAPs)
or conjugated to carrier proteins were used to immunize rats
and rabbits. Serum from immunized rats were used to test the
suitability of these targets using Enzyme Assays, Blot Assays and
Immunocytochemistry with worm sections.
Results: Results show that antibodies to MAPs have good speci-
ﬁcity for the peptides and native schistosome antigens while
coupling to carrier proteins improves the immunogenicity of the
peptides.
Conclusion: This approach has shown that these peptides are
possible diagnostic targets that can be developed further to assess
their sensitivity aiming at developing an assay capable of detecting
the lowest number of worms in the host.
http://dx.doi.org/10.1016/j.ijid.2014.03.1173
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Rapid detection of ESBL-producing
Enterobacteriaceae from blood cultures: A
prospective study
P. Nordmann1, L. Poirel1, L. Dortet2
1 University of Fribourg, Fribourg, Switzerland
2 Hopital de Bicetre, Kremlin-Bicetre, France
Background: Enterobacterial strains producing clavulanic-
acid inhibited extended-spectrum beta-lactamases (ESBLs) are
increasingly reported worldwide. The rapid detection of ESBL-
producing Enterobacteriaceae responsible for bacteremia is of
utmost importance since their successful treatment depends on
prompt administrationof the appropriate antimicrobial agents. The
ESBL NDP test has been evaluated here prospectively to detect
ESBL-producing Enterobacteriaceae directly from blood cultures.
Methods & Materials: From November 2012 to May 2013, the
ESBL NDP test, a rapid chromogenic test based on detection of cefo-
taxime hydrolysis, was performed with 96 blood cultures positive
for Gram negatives. Results of the ESBL NDP test, obtained in less
than 30min, were compared to those obtained with the double
disk diffusion technique. All ESBLs were then characterized at the
molecular level. Identiﬁcation of the Gram-negative bacteria was
also performed directly on positive blood cultures using MALDI-
TOF technology, and conﬁrmed by a biochemical identiﬁcation.
Results: Eighteen blood cultures infected with ESBL-producing
Enterobacteriaceae (15 CTX-M producing E. coli and 3 CTX-M
producing K. pneumoniae) were correctly detected, whereas 78
